Dec 31, 2024, 08:53 | Blog

Carmen Uscatu: What do you promise for 2025?

Carmen Uscatu, President and co-founder of Dăruiește Viață/Give Life, shared a post on LinkedIn: "I…

Dec 29, 2024, 12:02 | Science

Udhayvir Grewal's review on maintenance strategies in GEP-NECs after platinum based chemotherapy

Udhayvir Grewal, Resident Physician at Ochsner LSU Health Shreveport Academy medical centre, shared an article…

Dec 28, 2024, 18:11 | Blog

A Journey of Anita H from Denial to Survival with Colorectal Cancer - Colorectal Cancer Alliance

Colorectal Cancer Alliance shared a post on LinkedIn: "I ignored the symptoms of cancer for…

Dec 25, 2024, 14:47 | Science

Andrea Necchi: Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI

Andrea Necchi, Associate Editor of the Journal of Clinical Oncology, shared a recent article on…

Dec 25, 2024, 03:35 | Blog

Amol Akhade: Use of Dostarlimab plus niraparib in first line Advanced Ovarian Cancer

Amol Akhade, Senior consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals,…

Dec 24, 2024, 13:21 | Science

Total Body Irradiation vs Chemotherapy for Hematopoietic Stem Cell Transplant in Adult AML

Mostafa Faisal, Adjunct Assistant Professor at Alfaisal University, posted on X about recent paper by Hasaan…

Dec 23, 2024, 12:11 | Blog

Five articles suggested by Yüksel Ürün

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…

Dec 22, 2024, 06:06 | Dialogues

Beyond the Cancer Diagnosis: Dialogue with Camilla Magnusson, by Adrian Pogacian

In this new edition of "Beyond the Cancer Diagnosis," by Adrian Pogacian, Camilla Magnusson, a breast cancer…

Dec 21, 2024, 19:14 | Blog

Pembrolizumab plus chemotherapy with or without bevacizumab for metastatic cervical cancer

James P. Crowley, Professor of Medicine Emeritus at Brown University and serves as a volunteer…

Dec 20, 2024, 22:49 | Science

High-risk defining events in follicular lymphoma following front line immunochemotherapy

Raul Cordoba, Chair of Community Stakeholder Committee at European Hematology Association (EHA) and Coordinator of…

Dec 18, 2024, 11:36 | Blog

New Article on OncoDaily Medical Journal by Agop Y. Bedikian

The OncoDaily Medical Journal has published a new review article by Agop Y. Bedikian. Shushan…

Dec 18, 2024, 07:31 | Blog

Etienne Brain: Key SABCS presentation by Luca Malorni

Etienne Brain, Medical Oncologist at Institut Curie/Saint-Cloud, shared a post on LinkedIn: "Key SABCS presentation…

Dec 17, 2024, 23:36 | Blog

Durvalumab and chemotherapy improves survival in MIBC - Uro Today

UroToday.com shared a post on X: "NIAGARA trial shows durvalumab + chemotherapy improves survival in…

Dec 15, 2024, 19:03 | Science

Real-world impact of the platinum chemotherapy shortage on US patients with advanced cancer

Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and…

Dec 13, 2024, 06:44 | Blog

Sara Tolaney: HER3DXd showed pCR and ORR rates similar to standard multi-agent chemotherapy

Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, shared a…

Dec 11, 2024, 19:07 | Blog

Reevaluating the role of platinum-based chemotherapy in the treatment landscape for advanced urothelial carcinoma

Enrique Grande shared on LinkedIn: "Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape…

Dec 11, 2024, 13:04 | Insight

Gustavo Viani: How to approach GEJ adenocarcinoma

Gustavo Viani, Professor of Radiation Oncology at Ribeirão Preto Medical School, University of Sao Paulo,…

Dec 10, 2024, 18:37 | Insight

Erman Akkus: Estimating chemotherapy toxicity in older adults

Erman Akkus, Medical Oncology fellow at Ankara University, shared a post on X: “Tools to…

Dec 10, 2024, 13:49 | Blog

Tom Powles: Sacituzumab govitecan vs chemotherapy in heavily pretreated UC

Tom Powles, Professor at the University of London, posted the following on X: “1/3 TROPICS-4: Sacituzumab govitecan…

Dec 9, 2024, 14:39 | Blog

Tom Powles: Terry Friedlander highlights multiple factors why SG did not beat chemotherapy in UC

Tom Powles, Professor at the University of London, shared a post on X: "TROPICS4 discusses…

Dec 9, 2024, 14:15 | Insight

S2013 and S1501 Reopen for Enrollment with Key Protocol Updates

Two pivotal SWOG NCORP Research Base trials, S2013 (I-CHECKIT) and S1501, have reopened for enrollment…

Dec 9, 2024, 13:18 | Insight

Pembrolizumab vs chemotherapy in MSI-high or MMR-deficient metastatic colorectal cancer

Shivani Modi shared a post on X: "Talk of the town! KEYNOTE-177 trial shows mFU: 73.3…

Dec 8, 2024, 06:30 | Insight

Tom Powles: Cisplatin or Carboplatin-Based Chemotherapy with Pembrolizumab in Advanced Urothelial Cancer

Tom Powles, Director of Barts Cancer Centre, shared a recent article on X: "While EVP…

Dec 7, 2024, 14:41 | Blog

Highlights from ESMO Asia 2024 by Angela Lamarca

The ESMO Asia Congress 2024 is currently taking place from December 6 to 8, 2024,…

Dec 7, 2024, 10:43 | Insight

Pembrolizumab vs Chemotherapy in microsatellite instability – high or mismatch repair – deficient metastatic colorectal cancer

Yakup Ergün, Medical Oncologist at Bower Hospital, shared a recent article by T. André on…

Dec 5, 2024, 15:28 | Insight

Christian Rolfo: Bintrafusp Alfa Plus Chemotherapy in Patients With Stage IV NSCLC

Christian Rolfo, Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials at…

Dec 5, 2024, 09:32 | Blog

Comparison of 1st chemotherapy in unresectable locally advanced or metastatic PDAC

Arndt Vogel shared on X: "Comparison of 1st chemotherapy in unresectable locally advanced or metastatic PDAC…

Dec 4, 2024, 13:07 | Insight

Gold-Based Drug Shows Potential for Targeted, Less Toxic Cancer Treatment

Gold-Based Drug Slows Tumor Growth by 82%, Offering Hope for Less Toxic Cancer Treatments. A…

Dec 2, 2024, 22:27 | Insight

Survival Outcomes with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer

Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a recent article by Peter Schmid…

Dec 1, 2024, 21:16 | Blog

James Crowley: Can Cancer Cells adapt faster than Evolution explains?

James Crowley, Professor of Medicine Emeritus at Brown University, shared a post on LinkedIn: "Can…

Dec 1, 2024, 14:39 | Blog

Nirmalee Perera: DPYD gene variant patterns in Fluoropyrimidine-based Chemotherapy Toxicity

Nirmalee Perera, Trainee embryologist at Hemas Hospitals, Sri Lanka, shared a post on LinkedIn: "I…

Dec 1, 2024, 11:07 | Blog

FDA approved Zanidatamab to treat Advanced Metastatic Biliary Tract Cancers - Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer shared a post on LinkedIn: "The FDA has approved the drug…

Nov 30, 2024, 19:38 | Insight

Stephen V Liu: Is there value in continuing osimertinib beyond progression?

Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a recent article by Tejas…

Nov 25, 2024, 13:47 | Blog

Herbert Loong Highlights Advances in Lung Cancer Therapies and Insights on HCC at IOHK2024

Immuno-Oncology Hong Kong 2024 Conference was held from November 23-24, 2024. It was hosted by…

Nov 24, 2024, 19:37 | Insight

Isabella Michelon: Meta-analysis of 2000+ patients with HER2-low and MBC

Isabella Michelon, 6th year medical student at the Catholic University of Pelotas, shared a recent…

Nov 20, 2024, 20:27 | Insight

HIPEC improves overall survival in recurrent epithelial ovarian cancer

Pramesh CS, Director at Tata Memorial Hospital, shared a recent article by Jean-Marc Classe on…

Nov 19, 2024, 20:55 | Blog

Rawia Mohamed: Updates and Insights on MMR in Colorectal Cancer

Rawia Mohamed, Head of the Anatomical Pathology Department at Burjeel Medical City, shared a post…

Nov 19, 2024, 20:45 | Insight

Pharmacogenomic predictors of common chemotherapy toxicities by Ivone U.S. Leong

Maryam Lustberg, Director of the Center for Breast Cancer at Yale Cancer Center, shared a…

Nov 16, 2024, 15:52 | Insight

Lucjan Wyrwicz: Immunotherapy in cancer is a story of success

Lucjan Wyrwicz, Head of Department, Dept. of Oncology and Radiotherapy at Maria Skłodowska-Curie Memorial Cancer…

Nov 16, 2024, 09:57 | Blog

Targeting expression in metastatic breast cancer - ASCO

ASCO posted the following on X: “Though ADCs have emerged as a cutting-edge approach to…

Nov 14, 2024, 14:40 | Dialogues

Advances in Head and Neck Cancer with Dr. Paolo Bossi | OncoInfluencers

In this episode of OncoDaily, Dr. Paolo Bossi, Associate Professor of Oncology at Humanitas University,…

Nov 14, 2024, 11:38 | Blog

Amol Akhade: Seeking insights on DYPD mutation testing in cancer treatment

Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post…

Nov 13, 2024, 09:11 | Blog

Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a recent article by…

Nov 13, 2024, 07:41 | Insight

Key Factors in Menstrual Recovery for Pre-menopausal Breast Cancer on Tamoxifen

Matteo Lambertini, Associate Professor at the University of Genoa and Medical Oncologist at San Martino…

Nov 11, 2024, 17:58 | Blog

COVID-19 Severity and Cancer Therapy

Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared a paper by Petros Grivas…

Nov 10, 2024, 19:34 | Cancer Types,Oncolibrary

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Pancreatic cancer is a malignant disease that originates in the tissues of the pancreas, an…

Nov 10, 2024, 02:00 | Insight

Nelson Dusetti: The applicability of our signatures in predicting treatment sensitivity and resistance in PDAC patients

Nelson Dusetti, Scientific Director of the company Predicting Med(CSO) and Chair of TRANSLATE-IT CRCM, shared an…

Nov 9, 2024, 20:08 | Blog

Dr. Sara Tolaney Discusses ESMO24 Insights on TroFuse-010 Trial in Advanced Breast Cancer

Dana-Farber’s Breast Oncology Center shared the following on X: “Dr. Sara Tolaney discussed ESMO24 Insights…

Nov 9, 2024, 13:59 | Blog

Wafik S. El-Deiry: Dr. Graham Walker on targeting translesion synthesis to overcome chemotherapy

Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and…

Nov 9, 2024, 12:35 | Blog

Amol Akhade: The choice of chemotherapy regimen for metastatic pancreatic cancer patients

Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post…

Nov 8, 2024, 14:27 | Dialogues

ASCO24 Updates - Dr. Mohammad Jad Moussa on Small Cell Bladder Cancer: Relapse Risks and pCR Impact

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Nov 5, 2024, 11:12 | Insight

Cathy Eng: Role of ctDNA in resected liver metastasis in colorectal cancer by Koshi Kataoka et. al

Cathy Eng, Co-Leader of the Gastrointestinal Cancer Research Program at the Vanderbilt-Ingram Cancer Center, posted…

Nov 5, 2024, 05:47 | Opinion

Kamala Harris vs Donald Trump on Cancer: From Cancer Moonshot to Right to Act, Funding, Research and Future

Cancer remains one of the most pressing health challenges of our time, affecting millions of…

Nov 4, 2024, 15:31 | Insight

Do patients with small ER+ tumors with high genomic risk benefit from chemotherapy?

An article by Florentine Hilbers, Postdoctoral Researcher at The Netherlands Cancer Institute, was recently mentioned by…

Nov 3, 2024, 15:49 | Blog

Paolo Cotzia: Investigating the role of immunotherapy in metastatic inflammatory breast cancer

Paolo Cotzia, Medical Director of Molecular Pathology and Head of Molecular Excellence at Sonic Healthcare…

Nov 3, 2024, 11:54 | Dialogues

Zolbetuximab: From Promising Drug to FDA Approval | Exclusive Interview with Astellas

In this episode of OncoDaily, Dr. Moitreyee Chatterjee-Kishore and Tomoko Nakajima from Astellas Pharma join…

Nov 2, 2024, 12:01 | Positive

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

As Pink October has ended, it's time to reflect on Breast Cancer Awareness Month. OncoDaily…

Nov 2, 2024, 03:25 | Blog

Chemotherapy Outcomes in Pregnant Breast Cancer Patients - ACS Journal Cancer

ACS Journal Cancer shared the following on X: “New! Women treated for breast cancer during…

Nov 1, 2024, 07:37 | Blog

Paolo Tarantino: ADCs combine the potency of chemotherapy with the PK of mAbs

Paolo Tarantino, Fellow at Dana-Farber Cancer Institute, shared a post on X: "ADCs combine the potency…

Nov 1, 2024, 01:53 | Insight

Cihangir Akyol: Age is not a barrier to colorectal cancer survival

Cihangir Akyol, Professor of Surgery at Ankara University, shared his recent article on X: "Age is not…

Oct 31, 2024, 13:04 | Blog

Megan-Claire Chase: No one goes through cancer unscathed

Megan-Claire Chase, Director of SHARE Cancer Support and Patient Advocate, shared this post on LinkedIn:…

Oct 31, 2024, 10:10 | Insight

Evaluating the Efficacy of Scalp Cooling on Hair Loss in Patients with Metastatic Breast Cancer: A Phase II Clinical Trial

We are pleased to announce the enrollment of participants for a pivotal Phase II clinical…

Oct 30, 2024, 16:04 | Blog

Richard Paxman: Raising Awareness of PCIA for Breast Cancer Awareness Month

Richard Paxman, Chief Medical Officer and Managing Director at Paxman, posted the following on LinkedIn:…

Oct 29, 2024, 17:57 | Insight

Beverly A. Zavaleta: Mouth Sores and Cancer Treatment Survey

Beverly A. Zavaleta, Physician Advisor at Tenet Healthcare, shared a post on X: “If you…

Oct 29, 2024, 15:42 | Blog

Megan-Claire Chase: No one goes through cancer unscathed

Megan-Claire Chase, Breast Cancer Program Director at Share Cancer Support, shared on LinkedIn: "Though this is…

Oct 29, 2024, 10:05 | Insight

Tips to prevent and reduce side effects on Braving Chemo by Beverly A. Zavaleta

Beverly A. Zavaleta, Physician Advisor at Tenet Healthcare, shared on X: “BIG thank you to…

Oct 28, 2024, 09:26 | Blog

Maryam Lustberg: A new multi PI R01 for patients living with chemotherapy induced neuropathy

Maryam Lustberg, Director of the Center for Breast Cancer at Smilow Cancer Hospital, shared a…

Oct 27, 2024, 20:06 | Blog

The Role of Lifestyle Modification in Enhancing Cancer Therapy Outcomes

Akash Maniam, Medical oncologist at Portsmouth Hospitals University NHS Trust, shared on Linkedin: ''Quite a…

Oct 26, 2024, 12:49 | Insight

Gustavo Viani: No Difference in Coronary artery disease Risk for Left- vs. Right-Sided Breast Cancer Treatment

Gustavo Viani, Associate Professor at the University of São Paulo, shared on LinkedIn: “Modern Radiotherapy…

Oct 26, 2024, 11:17 | Blog

Chandandeep Kaur: Advances in Preventing Chemotherapy-Induced Hair Loss

Chandandeep Kaur, Scientific Writer/Consultant at Happiest Health shared a post on LinkedIn: "Advances in Preventing…

Oct 25, 2024, 02:00 | Dialogues

ASCO24 Updates: Dr. Filippo Pietrantonio on ARMANI Trial Findings for Advanced Gastric Cancer

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Oct 24, 2024, 20:14 | Blog

Suhail Qureshi explains how scalp cooling works

Chandandeep Kaur, Science Writer and Consultant at Happiest Health, shared a post on X: ''Suhail…

Oct 24, 2024, 17:41 | Blog

Sami (Papacek) Mansfield: October is almost over but breast cancer awareness must continue

Sami (Papacek) Mansfield, Founder of Cancer Wellness for Life, shared a post by Total Health Oncology on…

Oct 23, 2024, 14:45 | Blog

Paolo Tarantino: How do we build a new generation of safer and more active ADCs for treating cancer

Paolo Tarantino and Raffaele Colombo shared posts on X, about recent paper published in Cancer…

Oct 23, 2024, 10:00 | Insight

MD Anderson Research Highlights

Featuring novel targets for breast cancer, epigenetic strategies to improve immune responses, a treatment for…

Oct 22, 2024, 15:58 | Blog

Anirban Maitra: Revolution Medicines has launched its phase 3 study of RMC-6236

Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center,…

Oct 22, 2024, 14:46 | Blog

Michelle Mitchell: Reflecting on CRUK's impact for people affected by cancer

Michelle Mitchell shared on Linkedin: ''I’ve spent the last couple of days in Birmingham with…

Oct 22, 2024, 11:52 | Blog

Anand Patel: Interesting article on adults over sixty years old with CBF-AML treated with intensive chemotherapy

Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago,…

Oct 21, 2024, 08:33 | Blog

Supriya Mohile: Challenges in chemotherapy outcomes for older adults

Supriya Mohile shared the following on X: “Dr. Zhihong Zhang (Sandy) reports that only 18…

Oct 20, 2024, 18:22 | Blog

Day 2 of the CCI Conference - Childhood Cancer International Europe

Childhood Cancer International - Europe shared the following on LinkedIn: “Commencing Day 2 of the…

Oct 20, 2024, 17:10 | Blog

Omnia Korani: Pembrolizumab plus chemotherapy did not improve DFS in high-risk endometrial cancer

Omnia Korani, Assistant Lecturer at the National Cancer Institute, shared a post on LinkedIn: “Adjuvant…

Oct 20, 2024, 13:37 | Dialogues

ASCO24 Updates: Andres Marmol-Perez on Sarcopenia in Childhood Cancer Survivors

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Oct 20, 2024, 12:48 | Insight

Reza Ghalehtaki: TNT is the new standard of care for LARC

Reza Ghalehtaki, Radiation Oncologist at Cancer Institue of Iran, shared a post on X: "Hot…

Oct 20, 2024, 11:38 | Blog

Maryam Lustberg: How minocycline Affects Cognition and Inflammation in Breast Cancer Survivors on Chemotherapy

Maryam Lustberg shared a post on Linkedin: ''Neuroinflammation from chemotherapy andover activated Microglia contribute to…

Oct 18, 2024, 14:42 | Blog

Paxman Scalp Cooling - Discussing Chemotherapy Induced Alopecia at Strength Early Onset Breast Cancer Conference

Paxman Scalp Cooling shared on Linkedin: ''This weekend, Jacqueline Olsen from our US team joined the…

Oct 17, 2024, 17:51 | Blog

Shahrin Ahmed: Liver Cancer Awareness Month

Shahrin Ahmed, Medical Specialist at Canadian Cancer Society, shared a post on X: ''Liver Cancer…

Oct 17, 2024, 16:20 | Insight

Aaron Goodman: One of my favorite differentials, Intestinal T/NK lymphoma

Aaron Goodman, Associate Professor of Medicine at the University of California, San Diego, shared a…

Oct 17, 2024, 12:57 | Insight

Antonio Calles: Massive news for patients with SCLC

Antonio Calles, Medical Specialist in Medical Oncology at Gregorio Marañón General University Hospital, shared a…

Oct 16, 2024, 13:33 | Blog

The importance of skeletal muscle in the outcomes of our individuals with cancer, with the new direction of immunotherapy and CAR T-cell therapy

Sami (Papacek) Mansfield, is the founder of Cancer Wellness for Life shared a post by…

Oct 15, 2024, 12:59 | Blog

Brendon Stiles: We owe it to our patients with EGFR mutations

Brendon Stiles, Professor and Chief, Thoracic Surgery and Surgical Oncology, Montefiore Health System shared a post on…

Oct 14, 2024, 10:30 | Insight

MHRA Approves Merck and Astellas/Pfizer's Bladder Cancer Combination Therapy

The MHRA has approved the combination of Keytruda (pembrolizumab) and Padcev (enfortumab vedotin) as a…

Oct 12, 2024, 22:16 | Insight

Triparna Sen: CD38-mediated immunosuppression as a potential mechanism of tumor cell escape from PDL1 inhibition in SCLC

Triparna Sen, Associate Professor, Icahn School of Medicine at Mount Sinai, shared a post on…

Oct 12, 2024, 10:30 | Insight

FDA Approves Inavolisib with Palbociclib and Fulvestrant for Advanced Breast Cancer

On October 10, 2024, the FDA approved inavolisib (Itovebi, Genentech, Inc.) in combination with palbociclib…

Oct 11, 2024, 16:52 | Blog

Nikolina Dodlek: Improving the quality of life and manage side effects of chemotherapy with Virtual Reality

Nikolina Dodlek, Cancer Nurse, UnitedHealthcare, Osijek, shared a post on X: "f you are (AYA)…

Oct 11, 2024, 13:58 | Blog

Francesco Massari: Global real-world experience in mUC treatment

Francesco Massari, Medical Oncologist focused on Genitourinary Cancer at The University Hospital of Bologna IRCCS, posted…

Oct 10, 2024, 16:36 | Blog

Jenna Fischer opens up about her brave battle with breast cancer

Jenna Fischer, the beloved actress known for her iconic role as Pam Beesly on the…

Oct 9, 2024, 10:29 | Blog

Shushan Hovsepyan: Finally got my hands on the wonderful book Nella Terra di Mezzo

Shushan Hovsepyan posted the following on LinkedIn: “Yesterday I finally got my hands on the…

Oct 8, 2024, 15:29 | Insight

Jarushka Naidoo: Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab in NSCLC

Jarushka Naidoo shared a post on X: “Long-Term Outcomes 1L Ipilimumab/Nivolumab/-Chemo v Chemo in PDL1<1%…

Oct 8, 2024, 12:47 | Insight

Intrinsic temperature increases ferroptosis evasion and chemotherapy resistance in Pancreatic Cancer, suggested by Anirban Maitra

Anirban Maitra shared a post on X: "Fascinating! Intrinsic temperature increase drives lipid metabolism towards ferroptosis…

Oct 7, 2024, 11:35 | Blog

Carla Tardif: Children with cancer from low-income households are three times more likely to die and two times more likely to relapse than their counterparts

Carla Tardif shared a post on LinkedIn, about recent article published on her LinkedIn: ''Parents…